Show simple item record

dc.contributor.authorTukulula, Matshawandile
dc.contributor.authorHayeshi, Rose
dc.contributor.authorGouveia, Luis
dc.contributor.authorPaixao, Paulo
dc.contributor.authorNaicker, Brendon
dc.date.accessioned2018-04-18T12:32:58Z
dc.date.available2018-04-18T12:32:58Z
dc.date.issued2018
dc.identifier.citationTukulula, M. et al. 2018. Functionalization of PLGA nanoparticles with 1,3-β-glucan enhances the intracellular pharmacokinetics of rifampicin in macrophages. Pharmaceutical research, 35(6): # 111. [https://doi.org/10.1007/s11095-018-2391-8]en_US
dc.identifier.issn0724-8741
dc.identifier.issn1573-904X (Online)
dc.identifier.urihttp://hdl.handle.net/10394/26791
dc.identifier.urihttps://link.springer.com/article/10.1007/s11095-018-2391-8
dc.identifier.urihttps://doi.org/10.1007/s11095-018-2391-8
dc.description.abstractPurpose Mycobacterium tuberculosis which causes tuberculosis, is primarily resident within macrophages. 1,3-β-glucan has been proposed as a ligand to target drug loaded nanoparticles (NPs) to macrophages. In this study we characterized the intracellular pharmacokinetics of the anti-tubercular drug rifampicin delivered by 1,3-β-glucan functionalized PLGA NPs (Glu-PLGA). We hypothesized that Glu-PLGA NPs would be taken up at a faster rate than PLGA NPs, and consequently deliver higher amounts of rifampicin into the macrophages. Methods Carbodiimide chemistry was employed to conjugate 1,3-β-glucan and rhodamine to PLGA. Rifampicin loaded PLGA and Glu-PLGA NPs as well as rhodamine functionalized PLGA and Glu-PLGA NPs were synthesized using an emulsion solvent evaporation technique. Intracellular pharmacokinetics of rifampicin and NPs were evaluated in THP-1 derived macrophages. A pharmacokinetic model was developed to describe uptake, and modelling was performed using ADAPT 5 software. Results The NPs increased the rate of uptake of rifampicin by a factor of 17 and 62 in case of PLGA and Glu-PLGA, respectively. Expulsion of NPs from the macrophages was also observed, which was 3 fold greater for Glu-PLGA NPs than for PLGA NPs. However, the ratio of uptake to expulsion was similar for both NPs. After 24 h, the amount of rifampicin delivered by the PLGA and Glu-PLGA NPs was similar. The NPs resulted in at least a 10-fold increase in the uptake of rifampicin. Conclusions Functionalization of PLGA NPs with 1,3-β-glucan resulted in faster uptake of rifampicin into macrophages. These NPs may be useful to achieve rapid intracellular eradication of Mycobacterium tuberculosisen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.subject1,3-β-glucanen_US
dc.subjectNanoparticle drug deliveryen_US
dc.subjectPharmacokinetic modellingen_US
dc.subjectPLGA nanoparticlesen_US
dc.subjectRifampicin intracellular concentrationsen_US
dc.titleFunctionalization of PLGA nanoparticles with 1,3-β-glucan enhances the intracellular pharmacokinetics of rifampicin in macrophagesen_US
dc.typeArticleen_US
dc.contributor.researchID26419904 - Hayeshi, Rose Khavogoi


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record